DHP Korea Co. Ltd Asset Resilience Ratio
DHP Korea Co. Ltd asset resilience ratio. DHP Korea Co. Ltd (131030) has an Asset Resilience Ratio of 1.13% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See how many days can DHP Korea Co. Ltd fund operations to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of DHP Korea Co. Ltd (2014–2024)
Asset resilience ratio of DHP Korea Co. Ltd from 2014 to 2024. This chart shows how DHP Korea Co. Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of DHP Korea Co. Ltd for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down DHP Korea Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of DHP Korea Co. Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩1.99 Billion | 1.13% |
| Total Liquid Assets | ₩1.99 Billion | 1.13% |
Asset Resilience Insights
- Limited Liquidity: DHP Korea Co. Ltd maintains only 1.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
DHP Korea Co. Ltd Industry Peers by Asset Resilience Ratio
Compare DHP Korea Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276 |
Drug Manufacturers - Specialty & Generic | 0.16% |
|
Sandoz Group AG
SW:SDZ |
Drug Manufacturers - Specialty & Generic | 7.89% |
|
H Lundbeck A/S
CO:HLUN-B |
Drug Manufacturers - Specialty & Generic | -0.56% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566 |
Drug Manufacturers - Specialty & Generic | 47.16% |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518 |
Drug Manufacturers - Specialty & Generic | 0.00% |
|
Viyash Scientific Limited
NSE:SEQUENT |
Drug Manufacturers - Specialty & Generic | 0.08% |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153 |
Drug Manufacturers - Specialty & Generic | 1.81% |
DHP Korea Co. Ltd Asset Resilience Ratio by Year (2014–2024)
DHP Korea Co. Ltd asset resilience ratio by year from 2014 to 2024. The table below shows the annual Asset Resilience Ratio data for DHP Korea Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 18.32% | ₩30.50 Billion ≈ $20.67 Million |
₩166.50 Billion ≈ $112.84 Million |
-17.62pp |
| 2023-12-31 | 35.94% | ₩53.71 Billion ≈ $36.40 Million |
₩149.46 Billion ≈ $101.29 Million |
-9.24pp |
| 2022-12-31 | 45.18% | ₩61.55 Billion ≈ $41.71 Million |
₩136.24 Billion ≈ $92.33 Million |
-4.49pp |
| 2021-12-31 | 49.66% | ₩69.55 Billion ≈ $47.13 Million |
₩140.04 Billion ≈ $94.90 Million |
-9.91pp |
| 2020-12-31 | 59.58% | ₩77.39 Billion ≈ $52.45 Million |
₩129.90 Billion ≈ $88.03 Million |
+1.45pp |
| 2019-12-31 | 58.13% | ₩69.15 Billion ≈ $46.86 Million |
₩118.97 Billion ≈ $80.62 Million |
+1.19pp |
| 2018-12-31 | 56.94% | ₩59.16 Billion ≈ $40.09 Million |
₩103.91 Billion ≈ $70.42 Million |
-0.63pp |
| 2017-12-31 | 57.57% | ₩54.45 Billion ≈ $36.90 Million |
₩94.57 Billion ≈ $64.09 Million |
+6.28pp |
| 2016-12-31 | 51.29% | ₩43.00 Billion ≈ $29.14 Million |
₩83.85 Billion ≈ $56.82 Million |
+47.18pp |
| 2015-12-31 | 4.10% | ₩3.00 Billion ≈ $2.03 Million |
₩73.14 Billion ≈ $49.57 Million |
+1.96pp |
| 2014-12-31 | 2.14% | ₩1.44 Billion ≈ $978.76K |
₩67.39 Billion ≈ $45.67 Million |
-- |
About DHP Korea Co. Ltd
OPTUS Pharmaceutical Co., Ltd. provides ophthalmic solutions in South Korea. The company offers dry eye preparation, antibiotics, anti-allergic preparation, steroids preparation, glaucoma treatment, and retinopathy treatment products. It also provides ETC, OTC, cosmetics, healthcare, and other products, as well as single-dose unit eye drops and eye care products under OEU& brand name. The company… Read more